Clinical Decision Support Systems (CDSS) Market Research Report – Forecast to 2027

臨床意思決定支援システム(CDSS)市場コンポーネント(ソフトウェア、サービス、ハードウェア)、製品(統合CDSS、スタンドアロンCDSS)、モデル(知識ベースCDSS、非知識ベースCDSS)、配信モード(オンプレミスCDSS、クラウドベースのCDSS)、アドバイスモード(アクティブCDSS、パッシブCDSS)、設定(入院患者の設定、外来診療設定)、タイプ(治療的臨床意思決定支援システム、診断的臨床意思決定支援システム)およびアプリケーション(高度な臨床意思決定支援システム、従来の臨床意思決定支援システム)— 2027年までの予測

ID: MRFR/HCIT/4580-CR | July 2018 | Region: Global | 100 Pages         

1 Report Prologue

2 Market Introduction

2.1 Definition 20

2.2 Scope Of The Study 20

2.3 Research Objective 20

2.4 Assumptions & Limitations 20

2.4.1 Assumptions 20

2.4.2 Limitations 20

2.4.3 Market Structure 21

3 Research Methodology

3.1 Primary Research Methodology 23

3.2 Secondary Research Methodology 24

3.3 Market Size Estimation 25

3.4 Forecast Model 25

4 Market Dynamics

4.1 Introduction 27

4.2 Drivers 27

4.2.1 Increasing Geriatric Population 27

4.2.2 Increasing Number Of Hospitals 28

4.2.3 Growing Demand For Data-Driven Technologies 28

4.2.4 Increasing Number Of Emergency Department (ED) Visits 28

4.3 Restraints 28

4.3.1 Risk Of Data Privacy 28

4.3.2 High Cost For The Implementation 29

4.3.3 Lack Of Skilled Healthcare IT Professionals 29

4.4 Opportunity 29

4.4.1 Advancements In The Healthcare IT Sector 29

4.5 Macroeconomics 29

4.6 Technology Trends 30

5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis 32

5.1.1 Bargaining Power Of Suppliers 32

5.1.2 Bargaining Power Of Buyers 32

5.1.3 Threat Of New Entrants 32

5.1.4 Threat Of Substitutes 33

5.1.5 Intensity Of Rivalry 33

5.2 Investment Opportunity Analysis 33

5.3 Value Chain Analysis 34

5.3.1 Inputs 34

5.3.2 Software Development Processes 34

5.3.3 Output 35

5.3.4 Marketing & Distribution 35

5.3.5 Post-Selling Services 35

5.4 Pricing Analysis 35

6 Global Clinical Decision Support Systems Market, By Component

6.1 Introduction 37

6.2 Software 38

6.3 Services 38

6.4 Hardware 38

7 Global Clinical Decision Support Systems Market, By Product

7.1 Introduction 40

7.2 Integrated CDSS 41

7.3 Standalone CDSS 41

8 Global Clinical Decision Support Systems Market, By Model

8.1 Introduction 43

8.2 Knowledge-Based CDSS 44

8.3 Non-Knowledge-Based CDSS 44

9 Global Clinical Decision Support Systems Market, By Delivery Mode

9.1 Introduction 46

9.2 On-Premise CDSS 47

9.3 Cloud-Based CDSS 47

10 Global Clinical Decision Support Systems Market, By Mode Of Advice

10.1 Introduction 49

10.2 Active CDSS 50

10.3 Passive CDSS 50

11 Global Clinical Decision Support Systems Market, By Setting

11.1 Introduction 52

11.2 Inpatient Settings 53

11.3 Ambulatory Care Settings 53

12 Global Clinical Decision Support Systems Market, By Type

12.1 Introduction 55

12.2 Therapeutic Clinical Decision Support Systems 56

12.3 Diagnostic Clinical Decision Support Systems 56

13 Global Clinical Decision Support Systems Market, By Application

13.1 Introduction 58

13.2 Advanced Clinical Decision Support Systems 59

13.3 Conventional Clinical Decision Support Systems 59

14 Global Clinical Decision Support Systems Market, By Region

14.1 Introduction 61

14.2 Americas 62

14.2.1 North America 65

14.2.1.1 U.S. 68

14.2.1.2 Canada 70

14.2.2 South America 73

14.3 Europe 76

14.3.1 Western Europe 79

14.3.1.1 Germany 82

14.3.1.2 France 84

14.3.1.3 U.K. 86

14.3.1.4 Italy 89

14.3.1.5 Spain 91

14.3.1.6 Rest Of Western Europe 93

14.3.2 Eastern Europe 96

14.4 Asia Pacific 99

14.4.1 Japan 102

14.4.2 China 104

14.4.3 India 106

14.4.4 Australia 109

14.4.5 Republic Of Korea 111

14.4.6 Rest Of Asia Pacific 113

14.5 Middle East & Africa 116

14.5.1 Middle East 119

14.5.2 Africa 121

15 Competitive Landscape

15.1 Company Share Analysis 125

16 Company Profiles

16.1 Wolters Kluwer Health 127

16.1.1 Company Overview 127

16.1.2 Financial Overview 127

16.1.3 Products Offering 128

16.1.4 Key Developments 128

16.1.5 SWOT Analysis 128

16.1.6 Key Strategy 128

16.2 Hearst Communications Inc 129

16.2.1 Company Overview 129

16.2.2 Financial Overview 129

16.2.3 Products Offering 129

16.2.4 Key Developments 129

16.2.5 SWOT Analysis 130

16.2.6 Key Strategy 130

16.3 Elsevier B.V. 131

16.3.1 Company Overview 131

16.3.2 Financial Overview 131

16.3.3 Products Offering 132

16.3.4 Key Developments 132

16.3.5 SWOT Analysis 132

16.3.6 Key Strategy 132

16.4 Agfa-Gevaert Group 133

16.4.1 Company Overview 133

16.4.2 Financial Overview 133

16.4.3 Products Offering 134

16.4.4 Key Developments 134

16.4.5 SWOT Analysis 134

16.4.1 Key Strategy 134

16.5 Athenahealth, Inc 135

16.5.1 Company Overview 135

16.5.2 Financial Overview 135

16.5.3 Products Offering 135

16.5.4 Key Developments 135

16.5.5 SWOT Analysis 136

16.5.6 Key Strategy 136

16.6 Siemens AG 137

16.6.1 Company Overview 137

16.6.2 Financial Overview 137

16.6.3 Products Offering 138

16.6.4 Key Developments 138

16.6.5 SWOT Analysis 138

16.6.6 Key Strategy 138

16.7 Carestream Health 139

16.7.1 Company Overview 139

16.7.2 Financial Overview 139

16.7.3 Products Offering 140

16.7.4 Key Developments 140

16.7.5 SWOT Analysis 140

16.7.6 Key Strategy 140

16.8 Epic Systems 141

16.8.1 Company Overview 141

16.8.2 Financial Overview 141

16.8.3 Products Offering 142

16.8.4 Key Developments 142

16.8.5 SWOT Analysis 142

16.8.6 Key Strategy 142

16.9 IBM 143

16.9.1 Company Overview 143

16.9.2 Financial Overview 143

16.9.3 Products Offering 144

16.9.4 Key Developments 144

16.9.5 SWOT Analysis 144

16.9.6 Key Strategy 144

16.10 Allscripts Healthcare Solutions 145

16.10.1 Company Overview 145

16.10.2 Financial Overview 145

16.10.3 Products Offering 146

16.10.4 Key Developments 146

16.10.5 SWOT Analysis 146

16.10.6 Key Strategy 146

16.11 Cerner Corporation 147

16.11.1 Company Overview 147

16.11.2 Financial Overview 147

16.11.3 Products Offering 148

16.11.4 Key Developments 148

16.11.5 SWOT Analysis 148

16.11.6 Key Strategy 148

16.12 NextGen Healthcare 149

16.12.1 Company Overview 149

16.12.2 Financial Overview 149

16.12.3 Products Offering 150

16.12.4 Key Developments 150

16.12.5 SWOT Analysis 150

16.12.6 Key Strategy 150

16.13 Medical Information Technology, Inc. 151

16.13.1 Company Overview 151

16.13.2 Financial Overview 151

16.13.3 Products Offering 152

16.13.4 Key Developments 152

16.13.5 SWOT Analysis 152

16.13.6 Key Strategy 152

17 Appendix

17.1 Discussion Blue Print 154

17.2 Recent Key Developments 156

17.3 References 157

18 List Of Tables

TABLE 1 PRIMARY INTERVIEWS 24

TABLE 2 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 37

TABLE 3 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SOFTWARE, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 4 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 5 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 6 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 40

TABLE 7 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INTEGRATED CDSS, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 8 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR STANDALONE CDSS, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 9 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 43

TABLE 10 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR KNOWLEDGE-BASED CDSS, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 11 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR NON-KNOWLEDGE-BASED CDSS, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 12 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 46

TABLE 13 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR ON-PREMISE, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 14 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR CLOUD-BASED, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 15 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 49

TABLE 16 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR ACTIVE CDSS, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 17 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR PASSIVE CDSS, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 18 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 52

TABLE 19 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 20 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 21 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 22 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEM, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 23 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEM, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 24 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 58

TABLE 25 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR ADVANCED CLINICAL DECISION SUPPORT SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 59

TABLE 26 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 59

TABLE 27 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 62

TABLE 28 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 62

TABLE 29 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 63

TABLE 30 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 63

TABLE 31 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 63

TABLE 32 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 63

TABLE 33 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 64

TABLE 34 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 64

TABLE 35 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 36 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 37 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 65

TABLE 38 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 66

TABLE 39 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 66

TABLE 40 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 66

TABLE 41 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 66

TABLE 42 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 67

TABLE 43 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 67

TABLE 44 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 45 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68

TABLE 46 U.S. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 68

TABLE 47 U.S. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 68

TABLE 48 U.S. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 69

TABLE 49 U.S. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 69

TABLE 50 U.S. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 69

TABLE 51 U.S. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 69

TABLE 52 U.S. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 53 U.S. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 54 CANADA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 70

TABLE 55 CANADA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 71

TABLE 56 CANADA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 71

TABLE 57 CANADA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 71

TABLE 58 CANADA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 71

TABLE 59 CANADA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 72

TABLE 60 CANADA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 61 CANADA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72

TABLE 62 SOUTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 73

TABLE 63 SOUTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 73

TABLE 64 SOUTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 73

TABLE 65 SOUTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 73

TABLE 66 SOUTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 74

TABLE 67 SOUTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 74

TABLE 68 SOUTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 69 SOUTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75

TABLE 70 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 76

TABLE 71 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 76

TABLE 72 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 77

TABLE 73 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 77

TABLE 74 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 77

TABLE 75 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 77

TABLE 76 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 78

TABLE 77 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 78 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 78

TABLE 79 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79

TABLE 80 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 79

TABLE 81 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 80

TABLE 82 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 80

TABLE 83 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 80

TABLE 84 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 80

TABLE 85 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 81

TABLE 86 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 87 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81

TABLE 88 GERMANY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 82

TABLE 89 GERMANY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 82

TABLE 90 GERMANY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 82

TABLE 91 GERMANY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 82

TABLE 92 GERMANY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 83

TABLE 93 GERMANY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 83

TABLE 94 GERMANY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 95 GERMANY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 84

TABLE 96 FRANCE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 84

TABLE 97 FRANCE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 84

TABLE 98 FRANCE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 85

TABLE 99 FRANCE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 85

TABLE 100 FRANCE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 85

TABLE 101 FRANCE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 85

TABLE 102 FRANCE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 103 FRANCE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 104 U.K. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 86

TABLE 105 U.K. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 87

TABLE 106 U.K. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 87

TABLE 107 U.K. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 87

TABLE 108 U.K. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 87

TABLE 109 U.K. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 88

TABLE 110 U.K. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 111 U.K. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 88

TABLE 112 ITALY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 89

TABLE 113 ITALY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89

TABLE 114 ITALY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 89

TABLE 115 ITALY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 89

TABLE 116 ITALY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 90

TABLE 117 ITALY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 90

TABLE 118 ITALY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 119 ITALY CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91

TABLE 120 SPAIN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 91

TABLE 121 SPAIN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91

TABLE 122 SPAIN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 92

TABLE 123 SPAIN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 92

TABLE 124 SPAIN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 92

TABLE 125 SPAIN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 92

TABLE 126 SPAIN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 127 SPAIN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93

TABLE 128 REST OF WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 93

TABLE 129 REST OF WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94

TABLE 130 REST OF WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 94

TABLE 131 REST OF WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 94

TABLE 132 REST OF WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 94

TABLE 133 REST OF WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 95

TABLE 134 REST OF WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 135 REST OF WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95

TABLE 136 EASTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 96

TABLE 137 EASTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 96

TABLE 138 EASTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 96

TABLE 139 EASTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 96

TABLE 140 EASTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 97

TABLE 141 EASTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 97

TABLE 142 EASTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 143 EASTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98

TABLE 144 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99

TABLE 145 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 99

TABLE 146 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100

TABLE 147 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 100

TABLE 148 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 100

TABLE 149 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 100

TABLE 150 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 101

TABLE 151 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 152 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101

TABLE 153 JAPAN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 102

TABLE 154 JAPAN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102

TABLE 155 JAPAN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 102

TABLE 156 JAPAN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 102

TABLE 157 JAPAN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 103

TABLE 158 JAPAN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 103

TABLE 159 JAPAN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 160 JAPAN CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 104

TABLE 161 CHINA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 104

TABLE 162 CHINA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104

TABLE 163 CHINA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 105

TABLE 164 CHINA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 105

TABLE 165 CHINA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 105

TABLE 166 CHINA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 105

TABLE 167 CHINA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 106

TABLE 168 CHINA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106

TABLE 169 INDIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 106

TABLE 170 INDIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 107

TABLE 171 INDIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 107

TABLE 172 INDIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 107

TABLE 173 INDIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 107

TABLE 174 INDIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 108

TABLE 175 INDIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 176 INDIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 108

TABLE 177 AUSTRALIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 109

TABLE 178 AUSTRALIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109

TABLE 179 AUSTRALIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 109

TABLE 180 AUSTRALIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 109

TABLE 181 AUSTRALIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 110

TABLE 182 AUSTRALIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 110

TABLE 183 AUSTRALIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 110

TABLE 184 AUSTRALIA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 111

TABLE 185 REPUBLIC OF KOREA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 111

TABLE 186 REPUBLIC OF KOREA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111

TABLE 187 REPUBLIC OF KOREA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 112

TABLE 188 REPUBLIC OF KOREA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 112

TABLE 189 REPUBLIC OF KOREA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 112

TABLE 190 REPUBLIC OF KOREA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 112

TABLE 191 REPUBLIC OF KOREA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 113

TABLE 192 REPUBLIC OF KOREA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113

TABLE 193 REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 113

TABLE 194 REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 114

TABLE 195 REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 114

TABLE 196 REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 114

TABLE 197 REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 114

TABLE 198 REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 115

TABLE 199 REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 115

TABLE 200 REST OF ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115

TABLE 201 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116

TABLE 202 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 116

TABLE 203 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 117

TABLE 204 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 117

TABLE 205 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 117

TABLE 206 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 117

TABLE 207 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 118

TABLE 208 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118

TABLE 209 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 118

TABLE 210 MIDDLE EAST CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 119

TABLE 211 MIDDLE EAST CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119

TABLE 212 MIDDLE EAST CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 119

TABLE 213 MIDDLE EAST CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 119

TABLE 214 MIDDLE EAST CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 120

TABLE 215 MIDDLE EAST CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 120

TABLE 216 MIDDLE EAST CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 120

TABLE 217 MIDDLE EAST CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121

TABLE 218 AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 121

TABLE 219 AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121

TABLE 220 AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION) 122

TABLE 221 AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 122

TABLE 222 AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE, 2020–2027 (USD MILLION) 122

TABLE 223 AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION) 122

TABLE 224 AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 123

TABLE 225 AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 123

TABLE 226 GLOBAL CLINICAL DECISSION SUPPORT SYSTEMS, COMPANY SHARE RANKING 2020 125


19 List Of Figures

FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES 25

FIGURE 2 DROCS: CLINICAL DECISION SUPPORT SYSTEMS MARKET 27

FIGURE 3 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET 32

FIGURE 4 VALUE CHAIN ANALYSIS: CLINICAL DECISION SUPPORT SYSTEMS MARKET 34

FIGURE 5 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT 2020 & 2027 (USD MILLION) 37

FIGURE 6 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT 2020 & 2027 (USD MILLION) 40

FIGURE 7 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL 2020 & 2027 (USD MILLION) 43

FIGURE 8 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE 2020 & 2027 (USD MILLION) 46

FIGURE 9 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODE OF ADVICE 2020 & 2027 (USD MILLION) 49

FIGURE 10 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING 2020 & 2027 (USD MILLION) 52

FIGURE 11 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE 2020 & 2027 (USD MILLION) 55

FIGURE 12 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 58

FIGURE 13 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY REGION, 2020 & 2027 (USD MILLION) 61

FIGURE 14 AMERICAS CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY REGION 2020 (%) 62

FIGURE 15 NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY COUNTRY 2020 (%) 65

FIGURE 16 EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY REGION 2020 (%) 76

FIGURE 17 WESTERN EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY COUNTRY 2020 (%) 79

FIGURE 18 ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY COUNTRY 2020 (%) 99

FIGURE 19 MIDDLE EAST & AFRICA CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY COUNTRY 2020 (%) 116

臨床意思決定支援システム市場

臨床意思決定支援システム(CDSS)は、ヘルスケアITの範囲で不可欠な部分です

セグメンテーション

コンポーネント別 Software Services Hardware
By Product Integrated Cdss Standalone Cdss
By Model Knowledge Based Cdss Non Knowledge Based Cdss
タイプ別 Therapeutic Clinical Decision Support Systems Diagnostic Clinical Decision Support Systems

キープレーヤー

  • Cerner Corporation
  • Meditech
  • Epic Systems Corporation
  • Athenahealth Inc
  • Allscripts
  • Carestream
  • Agfa-Gevaert Group
  • Elsevier B.V.

運転手

  • Increasing Geriatric Population
  • Growing Demand For Data-Driven Technologies
Speak to Analyst Request a Free Sample

臨床意思決定支援システム市場の概要


Market

Research Futureのレポートによると、臨床意思決定支援システム(CDSS)市場は、12%のCAGRの支援により、2023年までに17億6000万米ドルの所得水準を達成すると予想されています。


臨床意思決定支援システム(CDSS)は、ヘルスケアITの範囲において不可欠な部分です。画期的な技術の進歩により、CDSSの導入が促進され、迅速な意思決定、データ処理、患者ケアにおける高度なワークフロー能力が簡素化されます。このシステムの適応可能な機能は、臨床意思決定支援システムの市場動向を後押しする上で大きな役割を果たしています。


新型コロナウイルス分析


COVID-19のパンデミックは、ヘルスケアのエコシステム全体にわたるユニークな課題の存在を形作りました。病院と医療システムは、重症患者の膨大な流入と人員不足と能力の制限に直面しています。しかし、臨床医は、パンデミックの初期段階から学んだ知識とスキルをよりよく身につけています。


COVID-19における臨床意思決定支援ソフトウェアの使用が激化し、比類のないストレスによる意思決定のタイムラインを短縮しながら、一貫した医療データに対する世界的な要件が浮き彫りになりました。多くの医療提供者は、望ましい結果を迅速に配布できるように、臨床意思決定支援システムのベンダーを変更しています。その結果、フロントレスポンダーの1つである世界の重要なヘルスケアセンターのかなりの数で、臨床意思決定支援システムの価値と課題をよりよく理解することができました。したがって、ワークフローの統合を容易にするため、関連データを簡単に見つけられる形式での臨床意思決定支援の要請は、次の期間の市場の発展を強調すると推定されます。


臨床意思決定支援システム市場の動向



  • ドライバー


増加する老人人口


高齢者人口の急増は、このセグメントからの需要を効果的に最適化するために、臨床意思決定支援システムの市場動向を実装する際の成長の有望な範囲を作り出すと推定されています。


増え続ける病院


新興国におけるヘルスケアセクターの迅速な発展は、臨床意思決定支援アプリケーションの進歩の範囲を広げる上で重要な役割を果たすと推定されています。


データ駆動型テクノロジーに対する需要の高まり


ヘルスケア部門におけるデータ駆動型テクノロジーの集合的な重要性は、世界中の臨床意思決定支援システムの市場規模市場の発展を維持しています。


救急科(ED)の訪問回数の増加


進行中のパンデミックによる緊急訪問の急増は、最適な患者ケアを確保するために、CDSSの原因をさらに押し上げると推定されています。



  • 拘束


データプライバシーのリスク


データのアップロードは、機密性の高い健康関連データを入手する可能性のあるハッカーからの脆弱性につながると推定されており、市場にとって顕著なハードルの1つです。


導入コストが高い


現在のパンデミックの混乱による医療提供者の資金不足の現実は、成長の機会を減らすと推定されています



  • 機会


ヘルスケアITセクターの進歩


電子医療記録の出現と臨床意思決定支援システムとの統合の成功は、臨床意思決定支援システム市場の重要な推進力です。システムには、治療される特定の状態の性質と問題の病院の支出能力に応じて、さまざまなデバイスのキャストが含まれる場合があります。その使用の最初の数年間は、臨床意思決定支援システムは、サポートシステムというよりは臨床意思決定生成者のように使用され、医師は単に患者の治療にシステムの結果に依存していました。臨床意思決定支援システムを病院の全体的な機能メカニズムに統合することも、スタンドアロンの追加機能として使用されるシステムとは対照的に重要です。


臨床意思決定支援システム市場セグメントの概要


コンポーネント別


ソフトウェアセグメントは、有望な開発を示すと推定されています。


製品別


統合されたバリアントセグメントは、予測期間中により多くの牽引力を得ると推定されます。


モデル別


ナレッジベースのCDSSは、ペースの速い環境での効率レベルの向上により、より多くのシェアを獲得すると推定されています。


配送モード別


クラウドセグメントは、予測期間におけるより高いレベルのスケーラビリティを保証するため、より有望です。


アドバイスのモード別


アクティブセグメントは、特にCOVID-19シナリオの期間中に勢いを増すと推定されています。


[設定による]


入院患者の設定と外来治療セグメントは、予測期間中に同様のレベルの発達を示すと推定されます。


タイプ別


治療CDSSは、予測期間における診断CDSSよりも優位に立つと予測されています。しかし、診断CDSSは、今後数年間で有望な成長を示すと推定されています。


アプリケーション別


高度および従来のCDSSのセグメントは、今後の期間にわたって有利な成長を示すと推定されています。


臨床意思決定支援システム市場地域分析


北米地域に利益をもたらす資金調達のアクセシビリティ


北米の臨床意思決定支援企業は、地域のヘルスケアセクターが最先端の州であるため、世界市場をリードする可能性が高い。北米のヘルスケアセクターにおける技術的拡大は、この地域で多くの重要なプレーヤーが発生し、臨床意思決定支援システムのいくつかの進歩的なモデルへのアクセス可能性に向けられているため、持続的に進んでいます。この地域での医療費の増加は、今後地域の臨床意思決定支援システム市場を押し上げる可能性がさらに高くなります。


APAC地域、大量の患者ベースを活用する


アジア太平洋地域の臨床意思決定支援システムは、アジア太平洋地域のヘルスケアセクターの堅実な進化と、西側経済と同等のヘルスケアセクターの技術的進歩をもたらすための政府の取り組みの増加により、世界レベルで大きな進歩を遂げる可能性があります。


臨床意思決定支援システム市場の競争状況



  • Cerner

  • メディテック

  • エピックシステムズ株式会社

  • アテナヘルス株式会社

  • Allscripts

  • Carestream

  • Agfa-Gevaert グループ

  • エルゼビアB.V.

  • ハーストヘルス

  • ウォルターズ・クルーワー・ヘルス


最近の動向


2020年11月:企業が複雑なデータを実用的な洞察に変換するのを支援するエンタープライズソリューションのサプライヤーであるNanHealth, Inc. は、RNAシーケンシングが実現可能であるだけでなく、がんの検査において重要な臨床的価値をもたらす可能性があることを発見した研究の発行を宣言しました患者の正確な疾患生物学により、治療決定が強化され、成功の可能性が高くなります。この研究は、Nantomics, LLCおよびImmunityBio, Inc. と共同で実施されました。このレポートは、臨床的意思決定のためのホルマリン固定パラフィン包埋型(FFPE)由来のRNAトランスクリプトーム報告の使用可能性を調査することを目的としていました。


2020年12月:Zynx Healthは、ウェブサイトzynxhealth.comで入手できる、公的にアクセス可能なCOVID-19臨床意思決定支援を有意義に増やし、近代化したことを明らかにしました。Zynx Healthコンテンツに組み込まれた最新のアップデートは、米国感染症学会などの組織からの推奨事項で構成されています。これは、世界保健機関の米国疾病管理予防センターで大きな進歩を遂げる可能性があります。


臨床意思決定支援システム市場レポートの概要



  • コンポーネント


    • ソフトウェア

    • サービス

    • ハードウェア




  • プロダクト


    • 統合されたCDSS

    • スタンドアロン CDSS




  • モデル


    • ナレッジベースCDSS

    • 非知識ベースのCDSS



    Report Scope:
    Report Attribute/Metric Details
      Market Size   USD 1.76 Billion
      CAGR   12% (2018-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Component, Product, Model, Delivery Mode, Mode of Advice, Setting, Type and Application
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Cerner Corporation Meditech Epic Systems Corporation Athenahealth Inc Allscripts Carestream Agfa-Gevaert Group Elsevier B.V. Hearst health Wolters Kluwer Health
      Key Market Opportunities   Advancements In The Healthcare IT Sector
      Key Market Drivers

  • Increasing Geriatric Population
  • Growing Demand For Data-Driven Technologies


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The global clinical decision support system market is expected to touch USD 1.76 billion by 2023.

    The global clinical decision support system market was worth USD 890 million in 2017.

    The global clinical decision support system market can expand at 12% CAGR from 2018 to 2023.

    The Americas can lead the global clinical decision support system market till 2023.

    Wolters Kluwer Health, Allscripts, Meditech, Athenahealth, Inc, Cerner Corporation, Elsevier B.V., Hearst health, Carestream, Epic Systems Corporation, and Agfa-Gevaert Group are major players in the global clinical decision support system market.

Global Clinical Decision Support Systems Market: Competitive Landscape


Globally, various players are operating in the clinical decision support systems market. The Americas is a hub to major companies, generating maximum market share which has turned this region into a well-established market. These companies have expanded their operating units in various other regions as well. Moreover, other small and medium scale players generate revenue from the local market.


The top four companies including Meditech, Cerner Corporation, Epic Systems Corporation, and Allscripts that together accounted for about 60% of the total clinical decision support systems market, in 2017.


Meditech holds the first rank followed by Cerner Corporation, Epic Systems Corporation, and Allscripts. Meditech accounted for a major share as it only focuses on providing services and solutions to the healthcare industry. Initially, the company was involved in developing software for various verticals in the healthcare industry including hospitals, clinical departments, and clinical laboratories which perform various diagnostic tests. In the recent years, the company has expanded its product line in home healthcare, ambulatory, mental health, and long-term care settings, enhancing its revenue in the healthcare IT market. Additionally, in 2017, Meditech announced a collaboration with National Decision Support Company to integrate Meditech Electronic Health Record (EHR) solutions with National Decision Support Company’s CareSelect Imaging platform. Furthermore, in, 2015 Meditech collaborated with First Databank and Zynx to create Cloud-Based Clinical Decision Support Solutions.


Despite Meditech being the market leader in the global clinical decision support system (CDSS) market, Epic Systems was awarded the Best in KLAS award for the Healthcare Management Consulting Firm. It is the backbone for many of the largest IT integrated healthcare systems in the world serving more than 200 million patients worldwide. The company develops, installs, and supports software products for medical groups, hospitals, and integrated healthcare organizations. It caters to the needs of customers from community hospitals, academic facilities, children's organizations, safety net providers, and multi-hospital systems. Epic Systems with its healthcare solutions, is garnering a large number of customers in mid-size and large medical groups. Due to its easy to use, quick to implement, and highly interoperable qualities, it is likely to take up the major share in the coming future.


Cerner Corporation is most popular among large facilities. Unlike Epic, Cerner Corporation applies to virtually every size of the hospital. Cerner provides clinicians with up-to-date information integrated into existing EHRs and clinical workflows to allow for accurate ordering and prescription leading to optimal patient care. Additionally, in 2015, Cerner Corporation acquired Siemens IT, which further strengthened its foothold in the EHR market.


Allscripts is gaining popularity with its integrated EHR systems. It serves more than two lakhs physicians and 7.2 million patients through its patient engagement platform. Allscripts clinical solutions are designed to enhance the decisions of clinicians and to streamline their search for patient health records by assuring EHR integrations across the system. Additionally, in 2017, Allscripts acquired McKesson Corporation’s (“McKesson’s”) Enterprise Information Solutions (EIS) business division (the “EIS Business”), which provides certain software solutions to hospitals and health systems. This acquisition will enhance the market share of Allscripts.